Stockhub

MaxCyte, Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

23 September 2022

  • curprev 06:3806:38, 23 September 2022 95.149.241.133 talk 933 bytes +933 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electrop..."
Retrieved from "https://stockhub.co/research/MaxCyte,_Inc."